Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With Hyperfiltration

Trial Profile

Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With Hyperfiltration

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 05 Oct 2017

At a glance

  • Drugs Dapagliflozin (Primary) ; Metformin
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Sep 2017 Planned End Date changed from 1 Apr 2018 to 1 Apr 2019.
    • 28 Sep 2017 Planned primary completion date changed from 1 Apr 2018 to 1 Apr 2019.
    • 28 Sep 2017 Planned initiation date changed from 1 Oct 2016 to 1 Nov 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top